Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells-Reference-Cited by-同舟云学术

Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells

Published:2022-09 Issue: Volume:29 Page:979-995
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Madison Blair B.^ORCID,Patil Deepak,Richter Maximilian,Li Xianghong,Tong Min,Cranert Stacey^ORCID,Wang Xinxin,Martin Renata,Xi Haibin,Tan Yening,Weiss Leslie,Marquez Karl^ORCID,Coronella Julia,Shedlock Devon J.^ORCID,Ostertag Eric M.^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference56 articles.

1. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia;Kalos;Sci. Transl. Med.,2011

2. T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma;Ali;Blood,2016

3. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer;Verma;Breast Cancer Res.,2016

4. Genome engineering using the CRISPR-Cas9 system;Ran;Nat. Protoc.,2013

5. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity;Pattanayak;Nat. Biotechnol.,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on allogeneic CAR-T cells in hematological malignancies;Cancer Cell International;2024-09-03

2. Cas‐CLOVER‐mediated knockout of STAT1: A novel approach to engineer packaging HEK‐293 cell lines used for rAAV production;Biotechnology Journal;2024-09

3. Application of CRISPR/Cas-based gene-editing for developing better banana;Frontiers in Bioengineering and Biotechnology;2024-08-16

4. Generation of CAR-TSCM: CAR-T with super clutch;International Immunopharmacology;2024-07

5. Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review;Frontiers in Oncology;2024-06-07